Fig. 6: No overt toxic effects of B38-CAP on liver and kidney. | Nature Communications

Fig. 6: No overt toxic effects of B38-CAP on liver and kidney.

From: B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction

Fig. 6: No overt toxic effects of B38-CAP on liver and kidney.The alternative text for this image may have been generated using AI.

a, b Liver function test with measurements of aspartate aminotransferase (AST) (a) and alanine aminotransferase (ALT) (b) in the blood. c, d Kidney function assessment with measurements of BUN (c) and Creatinine (Cr) (d) in the blood. sham + vehicle (n = 7), sham + B38-CAP (n = 5), TAC + vehicle (n = 9), and TAC + B38-CAP (n = 8). All values are means ± SEM. Two-way ANOVA with Sidak’s multiple-comparisons test. Numbers above square brackets show significant P-values.

Back to article page